Form 4 Tracker
Joseph Shulman

Chief Technical Officer · 3 filings · Latest: Aug 13, 2026

RHYTHM PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RYTM
Joseph ShulmanChief Technical OfficerAug 13, 2026
Sale
$119.755,079$608.2K15,915
RYTM
Joseph ShulmanChief Technical OfficerAug 13, 2026
Option Exercise
$6.802,024$13.8K20,994
RYTM
JOSEPH J SHULMAN—Aug 13, 2026
Proposed Sale
$117.605,079$597.3K—
RYTM
Joseph ShulmanChief Technical OfficerFeb 1, 2026
Option Exercise
—16,968—25,477
RYTM
JOSEPH SHULMAN—Oct 30, 2025
Proposed Sale
$113.899,748$1.1M—
RYTM
JOSEPH SHULMAN—Oct 28, 2025
Proposed Sale
$111.552,815$314.0K—
RYTM
JOSEPH SHULMAN—Oct 16, 2025
Proposed Sale
$109.3514,437$1.6M—
RYTM
JOSEPH SHULMAN—Sep 2, 2025
Proposed Sale
$103.1516,781$1.7M—
RYTM
JOSEPH SHULMAN—Aug 21, 2025
Proposed Sale
$98.704,188$413.4K—
RYTM
JOSEPH SHULMAN—Aug 11, 2025
Proposed Sale
$91.983,984$366.4K—
RYTM
JOSEPH J SHULMAN—Jul 9, 2025
Proposed Sale
$65.147,969$519.1K—
RYTM
JOSEPH J SHULMAN—Nov 11, 2024
Proposed Sale
$67.3313,281$894.2K—